axsomelogo-468x57.jpg
Axsome Therapeutics Initiates ACCORD Phase 3 Trial of AXS-05 in Alzheimer’s Disease Agitation
December 31, 2020 06:15 ET | Axsome Therapeutics, Inc.
ACCORD is the second pivotal trial of AXS-05 in Alzheimer’s disease agitation No treatments are currently approved for Alzheimer’s disease agitation NEW YORK, Dec. 31, 2020 (GLOBE...
download-2.png
Emerald Health Therapeutics’ Joint Venture Achieves Its Full Annualized Production Run-Rate
July 11, 2019 07:00 ET | Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, July 11, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc.’s (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) 50%-owned joint venture for large-scale, low-cost,...
PUCP occupies first place in Peru in the Scimago Institutions Rankings 2017
June 28, 2017 07:00 ET | Pontificia Universidad Católica del Perú
Lima - Perú, June 28, 2017 (GLOBE NEWSWIRE) -- June 28, 2017 - The Scimago Institutions Rankings (SIR) is an annual ranking of academic institutions related to research, which is based on...
GElektra.png
Grupo Elektra Reports 8% Decrease in EBITDA, to Ps.3,050 Million
April 23, 2013 19:34 ET | Grupo Elektra SAB de CV
—Firm expansion of credit business generates immediate costs and expenses, setting the stage for future profitability— —The company surpasses 6,500 points of sale in Mexico, the...
Anita Borg Institute Unveils Roster of Speakers Participating in Top Company for Technical Women Workshop
March 21, 2011 09:00 ET | Anita Borg Institute for Women and Technology
PALO ALTO, CA--(Marketwire - March 21, 2011) - The Anita Borg Institute for Women and Technology (ABI) announced today the speakers and topics for the inaugural Anita Borg Top Company for Technical...